Literature DB >> 24121815

Cotyledonoid dissecting leiomyoma as a possible cause of chronic lower back pain.

David O Onu1, Lisa M Fiorentino, Michael W Bunting.   

Abstract

Uterine fibroids having the distinct pathological and immunohistochemical features of cotyledonoid dissecting leiomyoma have been reported infrequently. We describe a postmenopausal woman with an incidental finding of an abdominopelvic mass arising from the uterine fundus on routine radiological imaging of the lumbar spine. The imaging was performed for the investigation of chronic radicular lower back pain refractory to usual pain management. However, the woman did not manifest any gynaecological symptoms. Intraoperatively, the pelvic mass appeared malignant and a frozen section suggested uterine sarcoma. As such, the mass was radically resected, resulting in significant resolution of the back pain. To the authors' knowledge, this is the first report of cotyledonoid dissecting leiomyoma presenting solely as chronic lower back pain, and also the first report of this fibroid variant in Australasia. We discuss the diagnostic and operative challenges, emphasising the role of radiological imaging and immunohistopathology in such cases and review current literature.

Entities:  

Mesh:

Year:  2013        PMID: 24121815      PMCID: PMC3822236          DOI: 10.1136/bcr-2013-201350

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  The frequency of uterine leiomyomas.

Authors:  S F Cramer; A Patel
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

Review 2.  A case of cotyledonoid leiomyoma and review of the literature.

Authors:  A Gurbuz; A Karateke; C Kabaca; H Arik; R Bilgic
Journal:  Int J Gynecol Cancer       Date:  2005 Nov-Dec       Impact factor: 3.437

3.  Cotyledonoid dissecting leiomyoma (Sternberg tumor): an unusual form of leiomyoma.

Authors:  F Menolascino-Bratta; V García de Barriola; M Naranjo de Gómez; J García Tamayo; J A Suarez; A V Hernández Chacón
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

Review 4.  Cotyledonoid dissecting leiomyoma of the uterus: a review of clinical, pathological, and radiological features.

Authors:  Catherine C Smith; Michael A Gold; Geoffrey Wile; Oluwole Fadare
Journal:  Int J Surg Pathol       Date:  2012-06-18       Impact factor: 1.271

5.  Cotyledonoid dissecting leiomyoma of the uterus. The Sternberg tumor.

Authors:  L M Roth; R J Reed; W H Sternberg
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

6.  Recurrent cotyledonoid dissecting leiomyoma of the uterus.

Authors:  Lawrence Max Roth; James A Kirker; Mark Insull; John Whittaker
Journal:  Int J Gynecol Pathol       Date:  2013-03       Impact factor: 2.762

7.  Cotyledonoid dissecting leiomyoma treated by laparoscopic surgery: a case report.

Authors:  Hirohiko Tanaka; Kuniaki Toriyabe; Tokihiro Senda; Yasufumi Sakakura; Kayo Yoshida; Tetsuo Asakura; Haruki Taniguchi; Kenji Nagao
Journal:  Asian J Endosc Surg       Date:  2013-05

Review 8.  Unusual types of smooth muscle tumors of uterine corpus: case reports and literature review.

Authors:  E Makharoblidze; N Goishvili; M Mchedlishvili; I Khakhutaishvili; M Jangavadze
Journal:  Georgian Med News       Date:  2013-03

9.  [Cotyledonoid dissecting leiomyoma of the uterus. A malignant-looking benign tumor].

Authors:  Sareni Chávez Martínez; María Leilanie Arias González; Rosa María Silva López; Jesús Angel Villagrán Uribe
Journal:  Ginecol Obstet Mex       Date:  2012-08

10.  Cotyledonoid dissecting leiomyoma of the uterus: a case report and review of the literature.

Authors:  Mi-Jin Kim; Yoon-Ki Park; Jae-Ho Cho
Journal:  J Korean Med Sci       Date:  2002-12       Impact factor: 2.153

  10 in total
  1 in total

1.  Cotyledonoid dissecting leiomyoma of the uterus: A report of four cases and a review of the literature.

Authors:  Tianmin Xu; Shuying Wu; Rulin Yang; Liping Zhao; Mingxing Sui; Manhua Cui; Weiqin Chang
Journal:  Oncol Lett       Date:  2016-03-08       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.